EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing

Lucy Rimmer, Derek A Mann, Avan A Sayer, Shoba Amarnath, Antoneta Granic

Frontiers in Immunology · 2024

DOI: 10.3389/fimmu.2024.1360141 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2024. Verfasst von Lucy Rimmer und 4 weiteren Autor:innen. Beteiligte Einrichtung: AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kin…. Hauptthemen laut MEDLINE: Clinical Relevance, Immunosenescence. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosenescence describes dysregulation of the immune system with ageing manifested in both the innate and adaptive immunity, including changes in T-cell checkpoint signaling. Through complex and nuanced process, T-cells lose excitatory signaling pathways and upregulate their inhibitory signaling, leading to ineffective immune responses that contribute to the formation of the ageing phenotype. Here we expand on the expression, function, and clinical potential of targeting the T-cell checkpoint signaling in age and highlight interventions offering the most benefits to older adults’ health. Notably, modifications in vaccination such as with mTOR inhibitors show immediate clinical relevance and good tolerability. Other proposed treatments, including therapies with monoclonal antibodies fail to show clinical efficacy or tolerability needed for implementation at present. Although T-cell co-signaling fits a valuable niche for translational scientists to manage immunosenescence, future study would benefit from the inclusion of older adults with multiple long-term conditions and polypharmacy, ensuring better applicability to actual patients seen in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical RelevanceImmunosenescenceHumansAgedAgingAdaptive ImmunityReceptors, Antigen, T-CellT-Lymphocytes

Stichwörter der Autor:innen

T-cellcheckpointhealthy ageingimmunosenescencetranslational research

Substanzen

Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Newcastle Fibrosis Research Group, Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust and Newcastle University, Newcastle upon Tyne, Un…
  • Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom.

Förderung

  • Cancer Research UK
  • Medical Research Council
  • Academy of Medical Sciences
  • NIHR Newcastle Biomedical Research Centre

Zitieren

APA

Rimmer, L., Mann, D. A., Sayer, A. A., Amarnath, S., & Granic, A. (2024). A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1360141

Vancouver

Rimmer L, Mann DA, Sayer AA, Amarnath S, Granic A. A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing. Frontiers in Immunology. 2024. doi:10.3389/fimmu.2024.1360141

BibTeX
@article{Rimmer2024,
  author = {Rimmer, Lucy and Mann, Derek A and Sayer, Avan A and Amarnath, Shoba and Granic, Antoneta},
  title = {A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing},
  journal = {Frontiers in Immunology},
  year = {2024},
  doi = {10.3389/fimmu.2024.1360141}
}
Kostenlos starten →